Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,954 | 19,390 | 26,616 | 125,298 | 41,353 |
| Marketable Securities | 113,209 | 133,774 | 143,953 | 79,194 | 81,597 |
| Receivables | 7,531 | 6,500 | 3,338 | 2,489 | 2,443 |
| TOTAL | $135,567 | $162,223 | $176,535 | $209,946 | $127,372 |
| Non-Current Assets | |||||
| PPE Net | 8,522 | 9,273 | 9,926 | 10,934 | 11,673 |
| Investments And Advances | 25,223 | 15,062 | 13,747 | 0 | 0 |
| Other Non-Current Assets | 2,366 | 2,254 | 2,250 | 2,259 | 5,981 |
| TOTAL | $36,111 | $26,589 | $25,923 | $13,193 | $17,654 |
| Total Assets | $171,678 | $188,812 | $202,458 | $223,139 | $145,026 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,843 | 5,806 | 5,766 | 4,724 | 3,182 |
| Accounts payable and accrued liabilities | 4,549 | 4,516 | 3,395 | 3,061 | 4,594 |
| Accrued Expenses | 4,628 | 3,565 | 2,502 | 6,217 | 4,085 |
| Other current liabilities | 589 | 832 | 443 | 847 | 815 |
| TOTAL | $35,859 | $36,099 | $31,130 | $36,423 | $36,905 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,500 | 7,000 | 8,500 | 10,000 | 11,500 |
| Deferred Revenues | 20,250 | 21,380 | 19,024 | 21,574 | 24,229 |
| Other Non-Current Liabilities | 129 | 125 | 121 | 102 | 1,531 |
| TOTAL | $25,913 | $33,158 | $40,610 | $55,177 | $62,309 |
| Total Liabilities | $61,772 | $69,257 | $71,740 | $91,600 | $99,214 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,309 | 2,293 | 2,293 | 2,293 | 2,285 |
| Common Shares | 23 | 23 | 23 | 23 | N/A |
| Retained earnings | -180,956 | -168,044 | -154,251 | -150,328 | -148,835 |
| Other shareholders' equity | 223 | 213 | 56 | -47 | 187,219 |
| TOTAL | $109,906 | $119,555 | $130,718 | $131,539 | $45,812 |
| Total Liabilities And Equity | $171,678 | $188,812 | $202,458 | $223,139 | $145,026 |